1. Herceptin ® in the adjuvant setting 2. Herceptin ® in the adjuvant setting: rationale HER2 overexpression is an early event in breast cancer development and is associated…
Herceptin® adjuvant therapy: “a triumphal narrative of translational research” Brian Leyland-Jones McGill University Department of Oncology Montreal, Quebec, Canada…